Feasibility of parental collected nasal swabs for virus detection in young children with cystic fibrosis  by Gangell, C.L. et al.
Original Articlewww.elsevier.com/locate/jcf
Journal of Cystic Fibrosis 13 (2014) 661–666Feasibility of parental collected nasal swabs for virus detection in
young children with cystic ﬁbrosisC.L. Gangell a,⁎, C. Shackleton a, S. Poreddy b, J. Kappers c, J.E. Gaydon a,d, T.P. Sloots a,d,
S.M. Stick b, S.C. Ranganathan c, P.D. Sly a
a Queensland Children's Medical Research Institute, The University of Queensland, Herston, Queensland 4029, Australia
b Centre for Child Health Research, The University of Western Australia, Subiaco, Western Australia 6008, Australia
c Department of Respiratory Medicine, Royal Children's Hospital, Melbourne, Victoria 3052, Australia
d Queensland Paediatric Infectious Diseases Laboratory, Royal Children's Hospital, Brisbane, Queensland 4029, Australia
Received 3 December 2013; received in revised form 4 February 2014; accepted 24 February 2014
Available online 15 March 2014Abstract
Background: The detrimental role of viruses has been well described in CF, although the pattern of virus infections has not been investigated in a
longitudinal study. The primary aim was to determine the feasibility of fortnightly parent collected swabs in young children with CF.
Methods: Children under three years with CF were recruited. Nasal swabs were collected by parents every fortnight and during periods of
symptoms over 12 months. Nasal swabs were posted and virus detected using real-time PCR.
Results: Only 27% of the patients completed the study to 10 months, although 98% of the swabs returned were adequate for analysis. Mould was
observed growing on 23% of the returned swabs. There was no evidence to demonstrate relationships with symptoms and viruses, prolonged
symptoms, prolonged shedding or patterns of virus infections.
Conclusions: This study highlights the need to further investigate the role of viruses in children with CF using a robust method of frequent
collection in children for a longitudinal study, with appropriate storage and shipping techniques to avoid mould growth or other potential
contaminants.
© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Virus; Cystic ﬁbrosis; Paediatric1. Introduction
Cystic fibrosis (CF) is a common hereditary condition amongst
Caucasians affecting multiple body systems, in particular the
respiratory system. Onslaughts of infection and inflammation lead
to progressive lung damage which begins early in life [1]. The role
of viruses contributing to worsening symptoms and associations⁎ Corresponding author at: Queensland Children's Medical Research Institute
The University of Queensland, Level 4, Foundation Building, Royal Children's
Hospital, Herston Road, Herston, QLD 4029, Australia. Tel.: +61 7 3636 4074
fax: +61 7 3636 5578.
E-mail address: c.gangell@uq.edu.au (C.L. Gangell).
http://dx.doi.org/10.1016/j.jcf.2014.02.009
1569-1993/© 2014 European Cystic Fibrosis Society. Published by Elsevier B,
;.V. Awith exacerbations and hospitalisations in children with CF has
been well described [2–5].
Children, defined as under the age of 18 years, with CF have
increased number of viruses [6], increased viral load [7], longer
periods of upper and lower respiratory infections (URI and
LRI) [5], and increased rates of hospitalisation [2] compared to
controls. Isolation of virus, either by serology or nasal swabs,
was associated with worse clinical outcomes including FEV1,
Shwachman scores and days of intravenous antibiotics [3,4].
This evidence suggests that infection with virus plays a
significant role in the pathogenesis of CF. However, the
epidemiology of virus infections in children with CF, particu-
larly during asymptomatic periods and over a period of time, is
not known.ll rights reserved.
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swabs from infants, collected by parents in their home, to detect
virus with a high rate of parent compliance at 74% [8]. Frequent
collection of nasal swabs for the detection of virus in a cohort
of children with CF would provide valuable information on
prevalence of viruses during asymptomatic periods, as well as
during periods of symptoms or exacerbations. However, the
feasibility of collection in a group such as this, in comparison to
a healthy cohort, has not been investigated.
The main aim of this pilot study was to determine the
feasibility of fortnightly parent collected swabs in young children
with CF. The secondary aims of this study were to identify
changes in virus detected between periods of symptoms and no
symptoms, and vice versa; and to observe differences in the type
of virus detected, and virus shedding, over a 12 month period in a
sub-set of children.
2. Methods
This study was conducted between May 2010 and November
2011 at the Princess Margaret Hospital in Perth, Royal Children's
Hospital inMelbourne and Royal Children's Hospital in Brisbane,
Australia. Children under the age of three years with a diagnosis of
CF were recruited for the 12 month study.
2.1. Ethics
Ethics was obtained at each site from the Princess Margaret
Hospital for Children Ethics Committee EC00268 (Approval
number 1762/EPP), Royal Children's Hospital Human Research
Ethics Committee EC00238 (Approval number 30086), and
Children's Health Services Human Research Ethics Committee
EC00175 (Approval number HREC/10/QRCH/24). Consent was
obtained from the parents of all participants recruited into the
study.
2.2. Study protocol
Baseline demographics including age, CF genotype and
pancreatic sufficiency were obtained. Parents were asked to
complete a daily diary for presence of solicited symptoms
including: fever, wheeze, shortness of breath, moist cough,
pneumonia, ear infection, runny nose, sore throat, cough, muscle
aches, chills, sore head, irritability, lethargy or vomiting.
Parents were taught by research staff on how to collect an
anterior nasal swab from their child using a flocked cotton swab
(147CV viral transport tube, COPAN). The swab transport tube
contained a foam pad soaked in viral transport medium. Nasal
swabs were collected every fortnight (routine swabs) and
within three days of the beginning of respiratory symptoms
(symptomatic swabs). Respiratory symptoms were wheeze,
shortness of breath, moist cough, pneumonia and cough.
Parents returned the daily symptom diary and the routine
and symptomatic nasal swabs by post every fortnight. Parents
were contacted by the study coordinator every fortnight and
reminded to take routine swabs from their child.2.3. Symptom classification
Respiratory symptoms were classified as upper respiratory
infections or lower respiratory infections based upon criteria from
a previous study [9]. Upper respiratory infections were classified
upon presentation of symptoms: runny nose or cough with no
other respiratory symptoms. Lower respiratory infections were
classified upon presentation of symptoms: wheeze, moist cough
or shortness of breath.
2.4. Virus analysis
Upon receiving samples at the research laboratory, swabs
were frozen at −80 °C until analysis. Quality of collection of the
nasal swabs and assessment of extraction efficiency were carried
out using previously described methods [10]. Briefly, samples are
spiked with Equine Herpes Virus to assess extraction efficiency,
and nasal specimens are assessed by determining the presence of
a marker of human genetic DNA [10,11].
Real-time PCR assays were performed on samples for
detection of the following viruses: picornaviruses (rhinoviruses
and enteroviruses), influenzae A & B, human metapneumovirus
(HMPV), parainfluenzae virus types I, II and III, respiratory
syncytial virus (HRSV-A and HRSV-B), adenovirus, bocavirus,
polyomavirus (hPy-V-WU, hPyV-KI), and coronavirus (OC43,
229E, NL63 and HKU1) [10]. Appropriate positive and negative
controls were used.
2.5. Statistics
Data are presented asmean and standard deviation (SD) unless
otherwise specified. During periods of symptoms (URI, LRI and/
or fever) which continued for three or more days, the mean
duration of symptoms in children where no virus was detected
was compared to periods where virus was detected using a
Mann–Whitney test. Data were excluded from this analysis if
there were no swabs taken during periods of symptoms, and if
symptom information was missing either side of the symptom
event.
3. Results
3.1. Feasibility
A total of 74 parents of children with CF were approached
with intent to stay in the study for the 12 month study
duration. Consent was formally withdrawn from nine
participant's families for reasons including; time commitment,
child refused swabs, additional time with physiotherapy and
other treatments, and parent unwell and unable to devote
additional time to research. The samples these participants
returned were included in the analysis. Only 20 children
completed the study to at least 10 months.
A total of 930 swabs were returned. Two swabs were
excluded as they were not labelled with a patient ID. Of the
remaining swabs 738 were routine, 168 were symptomatic
swabs, and 7 swabs were returned unlabelled as either routine
Table 2
Demographics of participants.
Cross-sectional
population
Longitudinal
population
n 54 20
Age (years) at first swab (mean ± SD) 1.79 ± 0.86 1.47 ± 0.81
Number of swabs collected per patient 8 ± 5 25 ± 3
Time (months) in study 5.3 ± 3.9 11.9 ± 1.1
Pancreatic sufficient (n(%)) 10 (18.5) 1 (0.5)
CF genotype (n(%))
Homozygous Phe508del 31 (57.4) 13 (65)
Heterozygous Phe508del 20 (37.0) 7 (35)
Other 3 (5.6) 0 (0)
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sample that was provided was not adequate for analysis. The
mean (±standard deviation) time between sample collection
and freezing in the laboratory was 6.1 ± 8.3 days.
Mould was observed growing on 23% of the swabs, ranging
from low growth (14%) to high growth (9%). Mould growth
was highest in Perth with 34% of the swabs affected, followed
by Melbourne with 23% of the swabs affected, then Brisbane
with 17% of the swabs affected. Swabs were still analysed
regardless of mould contamination. The time from swab
collection to freezing the swabs at −80 °C in the laboratory,
and season had an effect on mould growth (Table 1).3.2. Cross-sectional analysis
409 swabs were collected from 54 children over a period of
2.87 years, with the mean number of swabs returned per patient
as 8 ± 5 swabs. The mean time in the study for this group was
5.3 ± 3.9 months with the mean age at the start of the study as
1.79 ± 0.86 years. Table 2 displays the demographics of this
group.
Of the 96 symptom swabs that were returned, 37 (38.5%)
were positive for at least one virus. Of the 313 routine swabs
that were collected, 66 (21.1%) were positive for at least one
virus. Fig. 1 demonstrates viruses detected from routine and
symptomatic swabs by season. Of the viruses tested, rhinovirus
was the most common virus detected. More symptomatic swabs
were returned during winter, which was also the period when
the highest variety of viruses was detected.
There were 12 cases where more than one virus was
detected. The majority of cases were rhinovirus detected in
conjunction with coronavirus (n = 1), polyomavirus (n = 4),
adenovirus (n = 3), bocavirus (n = 2) or parainfluenzae (n = 1).Table 1
Mould growth by site, season and time to freezing.
Low growth High growth Total with mould
Site (% of swabs infected/swabs collected by site)
Brisbane 11 6 17
Melbourne 13 10 23
Perth 20 13 34
Season (% of swabs infected/swabs collected by in that season)
Autumn 12 11 24
Winter 15 10 25
Spring 14 8 22
Summer 14 8 22
Time to freezing (% of swabs infected/swabs collected by site)
Brisbane 0–4 days 7 0 7
5–9 days 23 21 45
≥10 days 20 35 55
Melbourne 0–4 days 8 3 11
5–9 days 14 16 30
≥10 days 22 33 55
Perth 0–4 days 7 3 11
5–9 days 25 6 31
≥10 days 28 26 55One case was identified where bocavirus and polyomavirus were
detected together.
In participants who returned more than one swab, a sub-set
analysis was undertaken to determine differences in virus
detected from a swab collected at the time of URI and/or LRI
(“symptomatic”) followed by an asymptomatic swab. Analysis
was conducted on 23 children from 37 visit pairs with a mean
time difference between symptomatic and asymptomatic swabs
of 18 ± 8 days. As Table 3 demonstrates there was no clear
pattern of virus detected between periods of symptoms followed
by clearance of symptoms.
A second analysis was conducted to look at the differences
in virus detected from an asymptomatic swab followed by a
symptomatic swab. Analysis was conducted on 18 children
from 35 visit pairs with a mean time difference between
asymptomatic and symptomatic swabs of 16 ± 12 days. As
Table 3 demonstrates there was no clear pattern of virus
detected between periods of no symptoms followed by onset of
respiratory infection.3.3. Longitudinal analysis
An average of 25 ± 3 swabs over a period of 11.9 ± 1.1 month
was collected from 20 children. These children were not part of the
cross-sectional population. Table 2 displays the demographics
for this population. On average, children had 2.9 ± 3.1 LRI and
5.9 ± 3.4 URI over the study period. This equated to, adjusting for
the amount of time each patient was enrolled in the study, an
average of 0.2 ± 0.2 LRI/child/month and 0.5 ± 0.3 URI/child/
month.
Data were observed for patterns of viral infections and
symptoms. During periods of symptoms (URI, LRI and/or fever)
which continued for three or more days, the mean duration of
symptoms in children where no virus was detected was 13.4 ±
8.7 days compared to periods where virus was detected which
was 14.8 ± 12.3 days (p = 0.93). There were no clear patterns
between onset of symptoms and isolation of virus, duration of
symptoms and isolation of type of virus, or isolation of virus and
duration or intensity of symptoms.
There were only eight cases where a new virus was detected
following clearance of another virus. There were not enough
data to analyse to determine if infection with one type of virus
increases susceptibility for infection with another virus. Over
Fig 1. Percent of nasal swabs returned which were positive for virus. Data are presented by virus, month collected, and the presence or absence of respiratory
symptoms. Asx = asymptomatic; Sx = symptomatic; White shading = summer, Dark grey shading = autumn, Black shading = winter; Light grey shading=spring.
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child admitted twice.
3.4. Virus shedding
Periods of virus shedding were analysed in the longitudinal
population of 20 participants. Overall, swabs were still positive
for virus for 13.0 ± 9.3 days, with swabs negative after 15.2 ±
7.7 days. Table 4 shows the shedding time by virus, although
data for each virus is limited due to small numbers of infections.
4. Discussion
The primary aim of this pilot study was to determine if
fortnightly parental collected nasal swabs were feasible in infants
and young children with cystic fibrosis. While the sample
collection was of good quality, the number of participants whoTable 3
Virus isolated between pairs of symptomatic and asymptomatic swabs.
n
Symptomatic swab followed by an asymptomatic swab
No virus detected at either visit 21
Virus detected at both visits 5
Virus detected at symptomatic (first) visit only 8
Virus detected at asymptomatic (second) visit only 3
Asymptomatic swab followed by a symptomatic swab
No virus detected at either visit 17
Virus detected at both visits 1
Virus detected at asymptomatic (first) visit only 6
Virus detected at symptomatic (second) visit only 11completed the study was small. This indicates that parental
collected fortnightly swabs in a population of young children
with cystic fibrosis may not be feasible without increased support
to participating families.
Detection of mould on swabs was unexpected, and infection
rates of 23% were high. The presence of mould was consistent
across seasons and was associated with location and time from
collection to freezing. We are confident that the presence of
mould did not compromise the detection of virus based on our
results, and results from other studies [12,13]. While there was
an increase in the variety of viruses detected on swabs during
winter in the present study, this is likely to be clinically related,
rather than a methodological issue due to storage temperatures.
However, we would recommend that parents store swabs in the
home freezer and return either by courier on ice, or deliver the
swabs to the site using cold-blocks and insulated bag to limit
mould contamination.Time between
swabs (days)
Symptoms (n)
URI LRI Both
18 ± 8 10 3 8
15 ± 8 2 2 1
19 ± 9 5 2 1
15 ± 2 1 2 0
19 ± 14 5 5 7
15 0 1 0
14 ± 9 3 2 1
14 ± 11 6 0 5
Table 4
Duration of shedding by virus.
Virus Time to next negative swab (days)
n Mean ± SD or [actual values]
Adenovirus 2 9.0 ± 7.1
Bocavirus 12 20.4 ± 10.1
Coronavirus 9 12.8 ± 3.7
Enterovirus 1 [5]
Influenza 1 [27]
MPV 3 13.7 ± 5.5
Parainfluenzae 3 16.3 ± 4.0
Polyomavirus 12 17.3 ± 10.0
Rhinovirus 58 14.5 ± 7.0
RSV 4 12.8 ± 2.8
Total 15.2 ± 7.7
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with only 15 of 932 (1.6%) swabs inadequate. However, of the
75 children enrolled in the study, only 20 children (26.6%)
completed 10 or more months of fortnightly collection. This is
in comparison to another study in a community cohort of
healthy preschool children where the return rates of parental
collected nasal swabs during periods of acute respiratory
infections over a period of 12 months were 74% [8].
This indicates that in this population collection of fortnightly
swabs may be a large burden on these families. Children with
CF need to undergo physiotherapy twice daily, plus follow a
strict medication regime. These treatments, plus participating in
a research study requiring a daily diary and fortnightly swabs
may be too much for some parents. A previous Australian study
has reported poor adherence to physiotherapy, with 50.4% of
patients aged 6 months to 6 years not compliant [14]. This
study also reported sleep problems (53.5%) and eating problems
(40.2%) in this age group of children with CF, as well as poor
parent mental health with depression (33.3%), anxiety (16.4%)
and stress (34.2%) all within the clinical range [14].
During the study, depending on the site, parents were contacted
by phone every two weeks. Diary cards were paper based, and
parents needed to post the swabs every two weeks using reply paid
envelopes which could be posted using normal postage methods.
To improve the compliance in a study such as this, a number of
methods could be employed. Firstly, it is important that a single
researcher establishes a good relationship with the parent and the
family. This helps the family to feel that they have a support person
they can contact during the study. Web-based diaries that could be
filled out by parents, or depending on the budget of the project
personal electronic diaries, have been shown to improve diary card
completion [15,16]. While reply-paid envelopes that could be
posted in standard Australia Post letterboxes were considered the
most efficient and cost-effective way of posting swabs, perhaps if
parents froze the nasal swabs and then a courier service collected
them it may help to improve compliance. However, courier
services, particularly with frozen samples, are expensive.
While the burden of a daily diary and fortnightly swabs in
this age group may be too great for participants and their
parents, fortnightly swabs were not frequent enough to provide
us with enough information about the pattern of viral infectionin this group. There was no evidence from the present study to
demonstrate relationships with symptoms and viruses, prolonged
symptoms with virus isolation, prolonged virus shedding or
patterns of virus infections in children with CF.
Rate of infections with URI in this study at 0.5 ± 0.3 URI/
child/month (this equates to 5.8 ± 3.4 URI/child/year) was at
the upper end of the number of infections reported in previous
studies in healthy preschool children with rates of 5.8 ARI/
child-month, 2.8 illness/child/year and 4.1 ARI/child/year
[8,17,18]. However, the data from the referenced studies were
collected in children attending daycare, or in the first year of
life and may be an over-representation of the number of
infections expected in healthy children.
Rhinovirus was the most commonly detected virus in this
study, at a mean prevalence of 14% in the cross-sectional
cohort, varying between 7 and 41% due to season. Similar rates
have been observed in previous studies which range from a
mean prevalence of 8% in infants [19] to between 7 and 27% in
children [6,7] and up to 84% in adults [3] with cystic fibrosis.
Prevalence of other viruses reported in the present study varied
compared to other studies in cystic fibrosis. Prevalence of
coronavirus was similar, although slightly higher in the present
study at 3% compared to others between 0 and 1.5% [6,20].
Prevalence of parainfluenzae was less in the present study at
1% compared to up to 17% in other studies [2,3,19,20]. As
expected rates of RSV were lower in this study at 1% compared
to infant studies which reported a prevalence of 23% [2,3,6,
19,20]. No influenza was detected in the cross-sectional group in
the present study, although studies have reported varied rates
between 1.5 and 30% [2,3,6,19]. The prevalence of adenovirus
was similar to another study in adults, although less than others in
children [2,3,20]. Differences in the prevalence of virus between
studies can be explained by a number of factors: age of children
(e.g. RSV ismore common in infants), time of year when samples
were taken (e.g. more influenza in winter), if samples were taken
at time of an exacerbation or when the participants were well or
symptom free, and if nasal/throat swabs or bronchoalveolar
lavage or nasopharyngeal aspirate was used.
Data from the present study must be interpreted with caution
as only a small sample size was used, and no data were collected
to compare viral infections with bacterial infection, or structural
and/or functional changes in this group. What this study does
show is that even during periods of no symptoms, virus may be
present in young children with CF; and infections do not seem to
differ compared to healthy children, although the consequences
of infections may be greater in older children [2–4].
In conclusion, researchers need to be aware of the equilibrium
between the burden of research on families and the scientific value
of results. This study highlights the need to further investigate the
role of viruses in children with CFwith a robust method of frequent
collection in children for a longitudinal study. Researchers need to
give consideration to good techniques for parent support and select
families who would be most compliant without introducing bias.
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